The Hill: A major pharmaceutical company lied and bypassed normal processes to push opioids on to patients who didn't need them, according to a new report released Wednesday by Sen. Claire McCaskill (D-Mo.)
The report is the first product of an investigation into opioid manufacturers and distributors led by McCaskill in her role as the ranking Democrat on the Senate's Homeland Security and Governmental Affairs Committee.
In one example, a representative of Insys Therapeutics Inc. misled a pharmacy benefit manager (PBM) into approving a payment for Subsys, a highly addictive fentanyl opioid meant to help manage cancer pain, the report says.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now